Article
FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma
27 Jun 2024
Abstract excerpt
BACKGROUND Stomach adenocarcinoma (STAD) is one of the main reasons for cancer-related deaths worldwide. This investigation aimed to define the connection between STAD and Cuproptosis-related genes (CRGs). Cuproptosis is a newly identified form of mitochondrial cell death triggered by copper. AIM To explore the identification of potential biomarkers for STAD disease based on cuproptosis. METHODS A predictive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
